Target intelligence / Profile preview

Colonic mucosal sensory nerve endings

Molecular classification
Other
01

Overview

Colonic mucosal sensory nerve endings and the local gastrointestinal (GI) milieu represent a physiological site of action rather than a single molecular target. This region encompasses the afferent nerve fibers, including C-fibers and A-delta fibers, that reside within the lamina propria and submucosa of the colon, as well as the surrounding chemical and physical environment (Source: NCBI, PMC3437337). These nerves are responsible for transmitting sensory information, such as distension and chemical irritation, from the gut to the central nervous system (Source: StatPearls, NBK534810). In many gastrointestinal disorders, particularly irritable bowel syndrome (IBS), these nerve endings become hypersensitive, a state known as visceral hypersensitivity. Pharmacological intervention at this site often involves locally acting agents that aim to dampen nerve excitability or provide a protective barrier without significant systemic exposure (Source: DrugBank, DB09211). Because this "target" encompasses a broad range of receptors and signaling pathways, it is often cited in pharmacological databases when a drug's effect is localized to the gut wall rather than a specific protein.

Other names
Non-specific colonic mucosal sensory nerve endingsLocal GI milieuColonic mucosal afferentsEnteric sensory nervesVisceral sensory endings
02

Mechanism of action

Drugs associated with this site typically exert local effects to modulate visceral afferent signaling, stabilize neuronal membranes, or reduce smooth muscle hyper-reactivity within the gut wall (Source: PubChem, CID 40467).

03

Biological functions

Sensory perceptionNociceptionGastrointestinal motilityLocal homeostasisSignal transduction
04

Disease associations

Irritable bowel syndromeFunctional gastrointestinal disordersVisceral hypersensitivityChronic abdominal painInflammatory bowel disease
05

Safety considerations

Local mucosal irritationMasking of underlying organic pathologyAlteration of normal gastrointestinal motilityPotential for unintended systemic absorption
06

Interacting drugs

Pinaverium bromide

6 more in the full profile.

07

Biomarkers

Visceral Sensitivity Index (VSI)Abdominal pain scoresFecal calprotectinGastrointestinal transit time

Beyond the preview

Go deeper on Colonic mucosal sensory nerve endings.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Colonic mucosal sensory nerve endings.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call